Multi-Tracer PET-Guided Therapy Selection and Theranostics in Radioiodine-Refractory Thyroid Cancer Patient Unsuitable for Tyrosine Kinase Inhibitor Therapy.

Saju A, Sonavane S, Basu S

Open source

DOI
10.1055/s-0045-1812056
Published
2026 Sep
Container
World journal of nuclear medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/s-0045-1812056,
  title = {Multi-Tracer PET-Guided Therapy Selection and Theranostics in Radioiodine-Refractory Thyroid Cancer Patient Unsuitable for Tyrosine Kinase Inhibitor Therapy.},
  author = {Saju A and Sonavane S and Basu S},
  year = {2026},
  journal = {World journal of nuclear medicine},
  doi = {10.1055/s-0045-1812056},
  url = {https://doi.org/10.1055/s-0045-1812056}
}

RIS

TY  - JOUR
TI  - Multi-Tracer PET-Guided Therapy Selection and Theranostics in Radioiodine-Refractory Thyroid Cancer Patient Unsuitable for Tyrosine Kinase Inhibitor Therapy.
AU  - Saju A
AU  - Sonavane S
AU  - Basu S
PY  - 2026
JO  - World journal of nuclear medicine
DO  - 10.1055/s-0045-1812056
UR  - https://doi.org/10.1055/s-0045-1812056
ER  - 

APA

A, S., S, S., & S, B. (2026). Multi-Tracer PET-Guided Therapy Selection and Theranostics in Radioiodine-Refractory Thyroid Cancer Patient Unsuitable for Tyrosine Kinase Inhibitor Therapy.. World journal of nuclear medicine. https://doi.org/10.1055/s-0045-1812056

Source records